European Commission risks repeating past mistakes in Urban Wastewater Treatment Directive cost study

Industry unites for a bold Critical Medicines Act that prioritises secure supply of medicines for patients

Open Letter to COREPER: Council’s homeopathic approach to Critical Medicines Act will succeed – in watering down EU health security

The president of Medicines for Europe talks about the need for an urgent pause in the adoption of the Extended Producer Responsibility (EPR) scheme under the Urban Waste Water Treatment Directive (UWWTD) to safeguard patient access and medicine supply while a fairer, more practical solution is reviewed.

Read the comment of our President and full Article below.

Open

SANT Committee prioritises manufacturing competitiveness in draft report on the Critical Medicines Act

Medicines for Europe intervenes in legal challenge against Urban Wastewater Treatment Directive’s EPR scheme

Pro-competitive policies matter for public health, for security and for strategic autonomy

Pharma reform should provide for more timely patient access in Europe

Medicines for Europe outlines trade policy recommendations to strengthen access to medicines and the competitiveness of EU manufacturing

Markus Sieger takes the helm as President ad interim at Medicines for Europe

Council agreement on review of EU pharmaceutical legislation